What is the dosing regimen for Bactrim (sulfamethoxazole/trimethoprim) in the treatment of hordeolum cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bactrim Dosing for Hordeolum Cellulitis

For hordeolum cellulitis, the recommended dosage of Bactrim (sulfamethoxazole/trimethoprim) is 1 double-strength tablet (160 mg trimethoprim/800 mg sulfamethoxazole) orally twice daily for 7-10 days. 1

Rationale for Dosing

  • Bactrim is effective against purulent cellulitis, including hordeolum cellulitis, which is often caused by Staphylococcus aureus, including community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) 1
  • The dosage of 1 double-strength tablet (160 mg trimethoprim/800 mg sulfamethoxazole) twice daily is the standard adult dose for skin and soft tissue infections 1, 2
  • For skin infections like hordeolum cellulitis, a 7-10 day course is typically recommended to ensure complete resolution and prevent recurrence 2, 3

Weight-Based Considerations

  • For optimal outcomes, weight-based dosing should be considered, particularly in patients who are overweight or obese 4
  • Adequate dosing is defined as ≥5 mg/kg/day of the trimethoprim component 4
  • Inadequate dosing has been associated with a significantly higher clinical failure rate (30% vs 17%) compared to adequate weight-based dosing 4

Special Populations

  • For patients with impaired renal function:
    • Creatinine clearance >30 mL/min: standard regimen 2, 3
    • Creatinine clearance 15-30 mL/min: half the usual regimen 2, 3
    • Creatinine clearance <15 mL/min: not recommended 2, 3
  • Bactrim is contraindicated in:
    • Pregnant women in the third trimester 1
    • Children under 2 months of age 2, 3
    • Patients with known hypersensitivity to sulfonamides 2

Efficacy and Monitoring

  • Bactrim has demonstrated high efficacy rates (91%) in treating skin infections in areas with high prevalence of CA-MRSA 5
  • Clinical improvement should be evident within 48-72 hours of initiating therapy 1
  • If no improvement is seen within 72 hours, consider:
    • Possible resistance to Bactrim
    • Need for incision and drainage if abscess formation has occurred
    • Alternative antibiotic therapy 1, 5

Potential Adverse Effects

  • Common adverse effects include rash, urticaria, nausea, vomiting, and gastrointestinal disturbances 6
  • Rare but serious adverse effects include:
    • Agranulocytosis (case reports exist even in healthy adults) 7
    • Stevens-Johnson syndrome
    • Toxic epidermal necrolysis 2
  • Monitor for signs of bone marrow suppression, especially in prolonged therapy or high doses 7, 8

Alternative Options

  • If Bactrim is contraindicated or not tolerated, consider:
    • Clindamycin 300-450 mg orally three times daily 1
    • Doxycycline 100 mg orally twice daily (not for children under 8 years) 1
    • Linezolid 600 mg orally twice daily (more expensive option) 1

Clinical Pearls

  • Incision and drainage should be performed if fluctuance is present, but antimicrobial therapy is still recommended for surrounding cellulitis 1
  • Patient should be advised to complete the full course of antibiotics even if symptoms improve rapidly 1
  • Warm compresses applied to the affected eye can help with symptomatic relief and may promote drainage 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.